Theravance Biopharma Ireland agrees potential $1bn deal

Theravance Biopharma Ireland agrees potential $1bn deal

The company, whose parent is listed on the Nasdaq, to do study on Crohn’s disease

Thu Feb 08 2018 - 11:44

The Counter Ruck

The Counter Ruck

Sign up to the Irish Times weekly rugby digest for the view from the press box with Gerry Thornley

YOU MAY ALSO LIKE...

Crosswords & Puzzles

Crosswords & Puzzles

Crosswords & puzzles to keep you challenged and entertained

Common Ground

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands

The Gloss

The GlossOpens in new window

Read the digital edition of The Gloss magazine now

Family Notices

Family NoticesOpens in new window

Weddings, Births, Deaths and other family notices

Opens in new window

Opens in new window

Why Subscribe?
Subscription Bundles
Subscriber Rewards
Student Subscription
Subscription Help CentreOpens in new window
Home DeliveryOpens in new window

Contact Us
Help CentreOpens in new window
My Account

Advertise
Contact Us
The Irish Times Trust
Careers

ePaper
Crosswords & puzzles
Newspaper Archive
Newsletters
Article IndexOpens in new window
Discount CodesOpens in new window

MyHome.ieOpens in new windowThe GlossOpens in new windowRecruit IrelandOpens in new windowIrish Times TrainingOpens in new windowRIP.ieOpens in new window

Irish Times on WhatsApp Irish Times on Facebook Irish Times on X Irish Times on LinkedIn Irish Times on Instagram

Terms & Conditions

Cookie Information

Cookie Settings

Community Standards

© 2025 The Irish Times DAC